DREAM Study: Can Omega-3 Treat Dry Eye Disease?

news banner

Penny Asbell, MD, FACS, MBA, Barrett G. Haik Endowed Chair for Ophthalmology, Chair, Department of Ophthalmology and Director, Hamilton Eye Institute at the University of Tennessee Health Science Center was interviewed at AAO 2018 regarding an update on the multicenter DREAM study evaluating omega-3 treatment for dry eye. In this clinical trial, patients with dry eye were given either omega-3 (2000-mg eicosapentaenoic acid and 1000-mg docosahexaenoic acid daily) or refined olive oil (5000 mg) and followed for one year. Both cohorts showed similar levels of improvement at the end of the study.

Based on these findings, which were published in the The New England Journal of Medicine, Dr. Asbell recommends physicians consider other approved and already available therapies for treating patients with dry eye.

Video interview link: